Lenalidomide shows significant benefit for myeloma patients, phase III study suggests
Wednesday, May 9, 2012 - 22:30
in Health & Medicine
Medical researchers report significant time-to-progression benefit as well as survival benefit for patients who took maintenance doses of lenalidomide following stem-cell transplant.